Basel Medical Group Ltd Ordinary Shares

BMGL · NASDAQ · Healthcare / Medical Care Facilities

0.47USD-0.10 (-17.54%)

Price History

Full chart

Market Stats

Previous Close0.57

Open0.53

Day Range0.4503 – 0.55

52-Week Range3.68 – 22.20

Volume613.36K

Market Cap5.85M

P/E (TTM)0.00

Forward P/E0.00

EPS-5.80

Dividend Yield0.00%

50-Day Avg5.20

200-Day Avg7.06

About

Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMr. Keng Leong Fung
Employees82
HeadquartersGleneagles Medical Centre, Singapore, Singapore, 258499, USA
Websitehttps://baselmedical.com

Leadership

Mr. Keng Leong FungExecutive Chairman of the Board · b. 1977
Mr. Boon Chye TanChief Commercial Officer & Director · b. 1981

Financials

Income Statement

Currency: SGD	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Revenue	10.66M	9.70M	10.05M	11.32M
Growth (%)	-	-8.98%	+3.60%	+12.63%
Cost of Revenue	2.18M	2.34M	2.25M	2.53M
Gross Profit	8.48M	7.36M	7.80M	8.79M
Gross Margin	79.56%	75.91%	77.63%	77.68%
Operating Expense	6.01M	5.36M	5.61M	10.98M
Operating Income	2.47M	2.00M	2.20M	-2.18M
Operating Margin	23.21%	20.64%	21.84%	-19.28%
EBITDA	3.28M	2.93M	3.11M	-11.12M
EBITDA Margin	30.80%	30.17%	30.94%	-98.24%
Net Income	1.98M	1.78M	2.07M	-12.09M
Net Income Margin	18.56%	18.38%	20.62%	-106.78%
Interest Expense	320.87K	238.60K	176.24K	203.95K
Interest Expense % of Total Revenue	3.01%	2.46%	1.75%	1.80%

Balance Sheet

Currency: SGD	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Total Assets	16.85M	15.38M	16.31M	16.85M
Total Liabilities	13.14M	9.89M	8.75M	11.99M
Total Equity	3.71M	5.49M	7.56M	4.86M
Cash	1.56M	1.22M	1.95M	2.98M
Total Debt	10.15M	7.21M	4.29M	3.42M
Net Debt	8.59M	6.00M	2.34M	440.39K

Cash Flow

Currency: SGD	2022-06-30	2023-06-30	2024-06-30	2025-06-30
Operating Cash Flow	2.79M	2.60M	2.51M	-4.34M
Investing Cash Flow	-88.50K	-6.16K	-7.92K	-11.04M
Financing Cash Flow	-12.92M	-2.94M	-1.77M	16.91M
Capital Expenditure	88.50K	6.16K	7.92K	54.76K
Free Cash Flow	2.70M	2.59M	2.50M	-4.40M
FCF to OCF	96.83%	99.76%	99.68%	101.26%

Earnings

Report Date	Nov 4, 2024	Jun 18, 2025	Nov 18, 2025
EPS Estimate	0.00	0.00	0.00
EPS Actual	0.05	-0.02	-0.55
Surprise	-	-	-
Timing	-	-	-

Key Statistics & Ratios

Market Cap5.85M

Enterprise Value12.46M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.40

Price / Book1.32

EPS-5.80

Book Value3.13

Revenue (TTM)14.74M

Gross Profit (TTM)2.06M

EBITDA-4.06M

Profit Margin-68.20%

Operating Margin-32.83%

Return on Equity-147.37%

Return on Assets-15.46%

Shares Outstanding1.58M

Shares Float512.60K

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Ownership Breakdown

Institutions: 0.07%
Insiders: 54.32%
Retail / Other: 45.61%

Top Institutional Holders

XTX Topco Ltd
25.76K0.14%
UBS Group AG
13.06K0.07%
Coston, McIsaac & Partners
500.00%
Susquehanna International Group, LLP
00.00%
T3 Companies, LLC
00.00%
Jane Street Group LLC
00.00%
Citadel Advisors Llc
00.00%
Bell Investment Advisors, Inc
00.00%
Ground Swell Capital, LLC
00.00%
Renaissance Technologies Corp
00.00%

Top Fund Holders

Fidelity Nasdaq Composite Index
5820.04%

Stock Splits

Jun 22, 20261:12